Krystal Biotech (KRYS) total liabilities

Total liabilities · fiscal 2025
$114.23M

Krystal Biotech (KRYS) had total liabilities of $114.23M at the end of fiscal 2025 (December 31, 2025). That is 4.4% higher than the $109.46M of fiscal 2024. Figures as of 19 Nov 2026, 11:29 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total liabilities, fiscal 2025
$114.23M
Change on fiscal 2024
+4.4%
Growth, 5 years
+43.5% a year
Highest on record
$114.23Mfiscal 2025
Lowest on record
$640.00Kfiscal 2017
Fiscal years on record
102016–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Krystal Biotech total liabilities, in more detail

Over the five fiscal years to 2025 total liabilities grew at a compound 43.5% a year. Across the 10 fiscal years on record (2016–2025), the highest was $114.23M in fiscal 2025 and the lowest $640.00K in fiscal 2017.

History · 10 fiscal years

Total liabilities by fiscal year

Krystal Biotech total liabilities, year by year

Krystal Biotech (KRYS) total liabilities by fiscal year
Fiscal yearTotal liabilitiesChangeYear ended
2025$114.23M 4.4% up
2024$109.46M 175.6% up
2023$39.71M 9.6% up
2022$36.22M 10.7% up
2021$32.72M 74.4% up
2020$18.76M 207.1% up
2019$6.11M 111.4% up
2018$2.89M 351.6% up
2017$640.00K 66.2% down
2016$1.89M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

Total liabilities at health care companies of similar size

Total liabilities of Krystal Biotech and comparable companies
CompanyTotal liabilitiesFiscal year
Praxis Precision Medicines PRAX$59.77M2025
Twist Bioscience TWST$233.79M2026
Protagonist Therapeutics PTGX$53.48M2025
Krystal Biotech KRYS$114.23M2025
10x Genomics TXG$245.04M2025
HealthEquity HQY$1.27B2026

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on KRYS

Krystal Biotech, figure by figure

Krystal Biotech (KRYS) overview: price, valuation and scorecardAll health care companies by market value

Krystal Biotech total liabilities: questions and answers

How large are Krystal Biotech's total liabilities?

Krystal Biotech (KRYS) had total liabilities of $114.23M at the end of fiscal 2025 (December 31, 2025). That is 4.4% higher than the $109.46M of fiscal 2024.

What is the growth rate of Krystal Biotech's total liabilities?

Over the five fiscal years to 2025 total liabilities grew at a compound 43.5% a year.

What are the highest and lowest total liabilities figures on record for Krystal Biotech?

Across the 10 fiscal years on record (2016–2025), the highest was $114.23M in fiscal 2025 and the lowest $640.00K in fiscal 2017.

How is Krystal Biotech's total liabilities calculated?

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For Krystal Biotech it is on record here for 10 fiscal years, 2016 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Krystal Biotech (KRYS) total liabilities”, data as of 19 November 2026. https://funkfolio.com/stock/KRYS/total-liabilities

Underlying data: the company's filings with the SEC and Yahoo Finance.